Wenzhou Kangning Hospital Co. Ltd (4WK) - Net Assets
Based on the latest financial reports, Wenzhou Kangning Hospital Co. Ltd (4WK) has net assets worth €1.31 Billion EUR (≈ $1.53 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.03 Billion ≈ $3.54 Billion USD) and total liabilities (€1.71 Billion ≈ $2.00 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of Wenzhou Kangning Hospital Co. Ltd to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.31 Billion |
| % of Total Assets | 43.35% |
| Annual Growth Rate | 2.6% |
| 5-Year Change | 3.19% |
| 10-Year Change | N/A |
| Growth Volatility | 4.54 |
Wenzhou Kangning Hospital Co. Ltd - Net Assets Trend (2016–2025)
This chart illustrates how Wenzhou Kangning Hospital Co. Ltd's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Wenzhou Kangning Hospital Co. Ltd to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Wenzhou Kangning Hospital Co. Ltd (2016–2025)
The table below shows the annual net assets of Wenzhou Kangning Hospital Co. Ltd from 2016 to 2025. For live valuation and market cap data, see 4WK company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €1.31 Billion ≈ $1.53 Billion |
-2.36% |
| 2024-12-31 | €1.34 Billion ≈ $1.57 Billion |
-4.61% |
| 2023-12-31 | €1.41 Billion ≈ $1.65 Billion |
+6.21% |
| 2022-12-31 | €1.33 Billion ≈ $1.55 Billion |
+4.31% |
| 2021-12-31 | €1.27 Billion ≈ $1.49 Billion |
-3.30% |
| 2020-12-31 | €1.31 Billion ≈ $1.54 Billion |
+4.19% |
| 2019-12-31 | €1.26 Billion ≈ $1.47 Billion |
+4.67% |
| 2018-12-31 | €1.21 Billion ≈ $1.41 Billion |
+8.53% |
| 2017-12-31 | €1.11 Billion ≈ $1.30 Billion |
+6.64% |
| 2016-12-31 | €1.04 Billion ≈ $1.22 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Wenzhou Kangning Hospital Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 160.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €364.23 Million | 30.66% |
| Other Components | €823.59 Million | 69.34% |
| Total Equity | €1.19 Billion | 100.00% |
Wenzhou Kangning Hospital Co. Ltd Competitors by Market Cap
The table below lists competitors of Wenzhou Kangning Hospital Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hanchang Ind.Co.Ltd
KQ:079170
|
$18.15 Million |
|
Blue Shark Power System SA
PA:MLBSP
|
$18.15 Million |
|
GUANGDONG KANG.CO.LTD YC1
F:E9Q
|
$18.15 Million |
|
Lleidanetworks Serveis Telematics SA
MC:LLN
|
$18.16 Million |
|
Naos Ex-50 Opportunities Company Ltd
AU:NAC
|
$18.15 Million |
|
Redflow Ltd
AU:RFX
|
$18.14 Million |
|
Asuransi Ramayana Tbk
JK:ASRM
|
$18.12 Million |
|
ACE LIBERTY+STONE LS -25
F:8MW
|
$18.12 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wenzhou Kangning Hospital Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,223,012,795 to 1,187,818,479, a change of -35,194,316 (-2.9%).
- Net income of 54,395,980 contributed positively to equity growth.
- Dividend payments of 72,902,783 reduced retained earnings.
- Other factors decreased equity by 16,687,512.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €54.40 Million | +4.58% |
| Dividends Paid | €72.90 Million | -6.14% |
| Other Changes | €-16.69 Million | -1.4% |
| Total Change | €- | -2.88% |
Book Value vs Market Value Analysis
This analysis compares Wenzhou Kangning Hospital Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.05x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €14.40 | €0.88 | x |
| 2018-12-31 | €14.85 | €0.88 | x |
| 2019-12-31 | €15.42 | €0.88 | x |
| 2020-12-31 | €16.24 | €0.88 | x |
| 2021-12-31 | €16.07 | €0.88 | x |
| 2022-12-31 | €16.11 | €0.88 | x |
| 2023-12-31 | €16.96 | €0.88 | x |
| 2024-12-31 | €16.83 | €0.88 | x |
| 2025-12-31 | €16.87 | €0.88 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wenzhou Kangning Hospital Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.58%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.36%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 2.55x
- Recent ROE (4.58%) is below the historical average (4.78%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 6.83% | 16.57% | 0.26x | 1.59x | €-32.01 Million |
| 2017 | 4.67% | 7.36% | 0.39x | 1.61x | €-56.11 Million |
| 2018 | 7.19% | 10.80% | 0.41x | 1.64x | €-31.50 Million |
| 2019 | 4.92% | 6.66% | 0.41x | 1.82x | €-59.16 Million |
| 2020 | 5.78% | 6.79% | 0.46x | 1.86x | €-51.18 Million |
| 2021 | 3.67% | 3.40% | 0.55x | 1.98x | €-75.86 Million |
| 2022 | -2.02% | -1.63% | 0.56x | 2.20x | €-144.38 Million |
| 2023 | 6.79% | 5.38% | 0.52x | 2.41x | €-40.56 Million |
| 2024 | 5.36% | 3.97% | 0.55x | 2.46x | €-56.69 Million |
| 2025 | 4.58% | 3.36% | 0.54x | 2.55x | €-64.39 Million |
Industry Comparison
This section compares Wenzhou Kangning Hospital Co. Ltd's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $6,159,034,054
- Average return on equity (ROE) among peers: -112.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wenzhou Kangning Hospital Co. Ltd (4WK) | €1.31 Billion | 6.83% | 1.31x | $18.15 Million |
| China Resources Medical Holdings Company Limited (1PH) | $6.85 Billion | 6.10% | 0.53x | $387.31 Million |
| AEST.MED.INT.HLD.SP.ADR/3 (3FMA) | $9.35 Million | -213.41% | 51.02x | $3.30 Million |
| JINXIN FERT.GRP HD-00001 (3NX) | $8.74 Billion | 1.39% | 0.74x | $656.44 Million |
| REVITALIST L.A.W. LTD (4DO) | $1.87 Million | -771.24% | 4.54x | $744.60K |
| HYGEIA HC HLDGS DL-00001 (50I) | $6.78 Billion | 2.43% | 0.57x | $10.27K |
| COMPASS PATHW SP.ADR (5Y6) | $225.74 Million | -52.48% | 0.22x | $657.30 Million |
| Bumrungrad Hospital Public Company Limited (BZ7A) | $18.84 Billion | 6.39% | 0.29x | $52.59K |
| Eifelhöhen-Klinik AG (EIF) | $12.61 Million | 0.67% | 1.87x | $10.05 Million |
| Fresenius Medical Care AG & Co. KGaA (FME) | $13.98 Billion | 6.93% | 1.46x | $10.01 Billion |
About Wenzhou Kangning Hospital Co. Ltd
Wenzhou Kangning Hospital Co., Ltd., together with its subsidiaries, operates a network of healthcare facilities in the People's Republic of China. The company provides psychiatric specialty care and elderly rehabilitation services. It is also involved in property leasing and management; provision of hospital management, medical services, technology, and nursing care services; drug retail and pha… Read more